TY - JOUR
T1 - Quantification of Soluplus for Dissolution Tests
T2 - SEC Method Development and Validation
AU - Horvath, Zoltan Mark
AU - Lauberte, Liga
AU - Mohylyuk, Valentyn
N1 - Publisher Copyright:
© 2024 American Pharmacists Association
PY - 2024/7/5
Y1 - 2024/7/5
N2 - The quantification of both polymer and drug during the dissolution of an amorphous solid dispersion (ASD) in aqueous media arouses great interest and may aid in the formulation. However, the available quantification methods for polymer excipients are limited, expensive, and challenging compared to drugs. In this work, a size exclusion chromatography method (HPLC-SEC) was developed and validated to determine the concentration of a frequently used polymer excipient, Soluplus® (Sol). In order to develop a method for the quantification of dissolved Soluplus®, two methods (SEC-UV and SEC-RID) with two injection volumes were tested with standard solutions of three different batches of Soluplus. The developed HPLC-SEC-UV method showed acceptable linearity (R2 > 0.9990) for all batches of Soluplus, good accuracies above a concentration of 0.1 mg/mL (coefficient of variation < 2%), relatively good precision at a concentration of 0.1 mg/mL (coefficient of variation < 2.5%), and high recoveries at a concentration of 0.75 mg/mL (coefficient of variation < 0.5%). The presence of Felodipine (Fel) and Lumefantrine (Lum) in the liquid media did not interfere with Soluplus quantification. The use of various surfactants, such as Tween® 80, Tween® 20, Span® 80, Span® 20, Kolliphor® TPGS, and sodium lauryl sulphate at a low concentration (0.005 mg/mL) did not show any effect on Soluplus® and did not interfere with Soluplus® quantification with any of the Soluplus batches. The addition of lithium bromide (LiBr) to the mobile phase within a concentration range of 0.05 to 1.0 M did not improve Soluplus® quantification.
AB - The quantification of both polymer and drug during the dissolution of an amorphous solid dispersion (ASD) in aqueous media arouses great interest and may aid in the formulation. However, the available quantification methods for polymer excipients are limited, expensive, and challenging compared to drugs. In this work, a size exclusion chromatography method (HPLC-SEC) was developed and validated to determine the concentration of a frequently used polymer excipient, Soluplus® (Sol). In order to develop a method for the quantification of dissolved Soluplus®, two methods (SEC-UV and SEC-RID) with two injection volumes were tested with standard solutions of three different batches of Soluplus. The developed HPLC-SEC-UV method showed acceptable linearity (R2 > 0.9990) for all batches of Soluplus, good accuracies above a concentration of 0.1 mg/mL (coefficient of variation < 2%), relatively good precision at a concentration of 0.1 mg/mL (coefficient of variation < 2.5%), and high recoveries at a concentration of 0.75 mg/mL (coefficient of variation < 0.5%). The presence of Felodipine (Fel) and Lumefantrine (Lum) in the liquid media did not interfere with Soluplus quantification. The use of various surfactants, such as Tween® 80, Tween® 20, Span® 80, Span® 20, Kolliphor® TPGS, and sodium lauryl sulphate at a low concentration (0.005 mg/mL) did not show any effect on Soluplus® and did not interfere with Soluplus® quantification with any of the Soluplus batches. The addition of lithium bromide (LiBr) to the mobile phase within a concentration range of 0.05 to 1.0 M did not improve Soluplus® quantification.
KW - Dissolution
KW - Polymer quantification
KW - Size exclusion chromatography
KW - Soluplus
KW - Validation
UR - https://pubmed.ncbi.nlm.nih.gov/38972546/
UR - http://www.scopus.com/inward/record.url?scp=85198536877&partnerID=8YFLogxK
U2 - 10.1016/j.xphs.2024.06.023
DO - 10.1016/j.xphs.2024.06.023
M3 - Article
SN - 0022-3549
JO - Journal of Pharmaceutical Sciences
JF - Journal of Pharmaceutical Sciences
ER -